Position in CTOR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,658,632
-$38,458 QoQ
Shares Held
8,705,589
-5.3% QoQ
Ownership
9.36%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#1
of 19 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CTOR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ARMISTICE CAPITAL, LLC holds $319,058,775 across 7 Drug Manufacturers - Specialty & Generic names. CTOR ranks #7 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SUPN |
Supernus Pharmaceuticals, Inc.
|
2,646,201 | $123,074,808 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
535,838 | $90,310,136 | |
| 3 | IRWD |
Ironwood Pharmaceuticals Inc
|
13,932,000 | $58,653,720 | |
| 4 | PBH |
Prestige Consumer Healthcare Inc.
|
336,000 | $15,882,720 | |
| 5 | XERS |
Xeris Biopharma Holdings, Inc.
|
1,958,702 | $15,512,919 | |
| 6 | EOLS |
Evolus, Inc.
|
1,436,000 | $9,965,840 | |
| 7 | CTOR |
Citius Oncology, Inc.
This page
|
8,705,589 | $5,658,632 |
All Filings in CTOR
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,079,809 | 9,353,553 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $5,658,632 | 8,705,589 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $5,697,090 | 9,188,855 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,584,080 | 5,584,080 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $15,582,099 | 7,675,911 | Shares | Sole | 2025-11-17 | |
| No filing history on record for this holder in this stock. | ||||||